2012598-71-7
Chemical Structure
Isoxepac-d6
Synonym(s): HP 549-d6
- CAS. Nr.: 2012598-71-7
- Formula:C16H6D6O4
- Molecular Weight:274.30
IUPAC Name: 2-(11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl-6,6,7,8,9,10-d6)acetic acid
InChIKey: QFGMXJOBTNZHEL-GBRSCYRESA-N
SMILES: O=C1C2=CC(CC(O)=O)=CC=C2OC([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C31
Biological Activity: Isoxepac-d6 (HP 549-d6) is the deuterium labeled Isoxepac (HY-W050088). Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Isoxepac-d6 | Isoxepac-d6 (HP 549-d6) is the deuterium labeled Isoxepac (HY-W050088). Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
